vorinostat has been researched along with Ependymoma in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Ependymoma: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorsi, HS | 1 |
| Toll, SA | 1 |
| Sood, S | 1 |
| Miler, S | 1 |
| Altinok, D | 1 |
| Kumar-Sinha, C | 1 |
| Mody, R | 1 |
| Yankelevich, M | 1 |
| Milde, T | 1 |
| Kleber, S | 1 |
| Korshunov, A | 1 |
| Witt, H | 1 |
| Hielscher, T | 1 |
| Koch, P | 1 |
| Kopp, HG | 1 |
| Jugold, M | 1 |
| Deubzer, HE | 1 |
| Oehme, I | 1 |
| Lodrini, M | 1 |
| Gröne, HJ | 1 |
| Benner, A | 1 |
| Brüstle, O | 1 |
| Gilbertson, RJ | 1 |
| von Deimling, A | 1 |
| Kulozik, AE | 1 |
| Pfister, SM | 1 |
| Martin-Villalba, A | 1 |
| Witt, O | 1 |
2 other studies available for vorinostat and Ependymoma
| Article | Year |
|---|---|
Ongoing Response in a Multiply Relapsed Metastatic Posterior Fossa Ependymoma A After Vorinostat and Concomitant Irradiation.
Topics: Child, Preschool; Combined Modality Therapy; Ependymoma; Histone Deacetylase Inhibitors; Humans; Mal | 2022 |
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Ependymoma; Gene Expression Profiling; Histone Deac | 2011 |